Zavabresib
Zavabresib (BET-IN-16) (Compound I) is a BET inhibitor. BET-IN-16 shows anticancer activity. Zavabresib inhibits prostate cancer cell growth, with IC50 values of 0.043 and 0.034 μM against LNCaP and 22Rv1 cells, respectively[1].
Product Specifications
CAS Number
2089390-09-8
Product Name Alternative
BET-IN-16
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bet-in-16.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C(C2=CN(C(C3=NC=CC=C3)(C)C4=NC=CC=C4)C5=C2N=CC(C6=C(C)ON=C6C)=C5)C=C1)O
Molecular Formula
C31H25N5O3
Molecular Weight
515.56
References & Citations
[1]Ben Powell, et al. Combinational drug anticancer therapies. Patent, WO2022040512A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
